teaser
Shire plc the global specialty biopharmaceutical company, will announce full year 2009 earnings on Friday 19 February 2010.
Results press release will be issued at: 12:00 GMT/07:00 EST
Investor conference call 14:00 GMT/ 09:00 EST
Angus Russell, Chief Executive Officer, Graham Hetherington, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Grgoire, President, Human Genetic Therapies will host the investor and analyst conference call at 14:00 GMT/9:00 EST.
The details of the conference call are as follows:
UK dial in: 0844 800 3850 or 01296 311 600
US dial in: 1 866 8048688 or 1 718 3541175
International dial in: +44 (0) 1296 311 600
Password/Conf ID: 587 261
